Search
for
Sort by
Research 91–120 of 1000+
- Severe Infliximab-Induced Alopecia and Scalp Psoriasis in a Woman with Crohn’s Disease: Dramatic Improvement after Drug Discontinuation and Treatment with Adjuvant Systemic and Topical Therapies
- 307 Dermatologic toxicities associated with chronic gamma-secretase inhibitor treatment for desmoid tumor
- Ruxolitinib 1.5% Topical Cream for the Treatment of Pediatric Alopecia Areata
- Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force “Dermatology for Cancer Patients” International Study
- ORAL AND TOPICAL FINASTERIDE IN THE TREATMENT OF MALE ANDROGENETIC ALOPECIA – NARRATIVE REVIEW
- Advances in Topical Therapies for Clinically Relevant and Prevalent Forms of Alopecia
- Development of Novel Mitochondrial Pyruvate Carrier Inhibitors to Treat Hair Loss
- Efficacy of topical tofacitinib in promoting hair growth in non-scarring alopecia: possible mechanism via VEGF induction
- Discovery of Natural Steroid 5 Alpha-Reductase Inhibitors
- Topical Inhibition of the Electron Transport Chain Can Stimulate the Hair Cycle
- Topical antiandrogens in the treatment of male-pattern baldness
- Hair Are the Rankings—5-α Reductase Inhibitors and Minoxidil in Male Androgenetic Alopecia
- Comparative Efficacy of Minoxidil and 5‐Alpha Reductase Inhibitors Monotherapy for Male Pattern Hair Loss: Network Meta‐Analysis Study of Current Empirical Evidence
- A Novel Topical Compound Gel Loading Minoxidil and Tofacitinib for Treatment of Alopecia Areata: Formulation, Characterization, and In Vitro/In Vivo Evaluation
- The relative effect of monotherapy with 5‐alpha reductase inhibitors and minoxidil for female pattern hair loss: A network meta‐analysis study
- Androgenetic Alopecia Treated With Topical Minoxidil. A Case Report and Review of Treatment Options
- TOPICAL PHARMACEUTICAL COMPOSITIONS
- Frontal fibrosing alopecia: treatment with oral dutasteride and topical pimecrolimus
- A quantitative hair growth assessment in androgenetic alopecia after application of two cosmetic lotions versus 2% topical minoxidil
- In silico prediction of prostaglandin D2 synthase inhibitors from herbal constituents for the treatment of hair loss
- Decoding Hyperpigmentation from Biological Mechanisms to Actives with Clinically Proven Topical Efficacy: A Narrative Review
- 688 Efficacy of topical Vorinostat in the reversal of alopecia areata
- Trichoscan: results using a 5% minoxidil topical solution in men with androgenetic alopecia
- [4-t-Butylphenyl]-N-(4-imidazol-1-yl phenyl)sulfonamide (ISCK03) inhibits SCF/c-kit signaling in 501mel human melanoma cells and abolishes melanin production in mice and brownish guinea pigs
- Development of Stratum Corneum Lipid Liposomes for Topical Drug Delivery
- Acneiform eruptions caused by an epidermal growth factor receptor-tyrosine kinase inhibitor ZD 1839
- Activity of 17β-(N-Alkyl/arylformamido) and 17β-[(N-Alkyl/aryl) alkyl/arylamido]-4-methyl-4-aza-5α-androstan-3-ones as 5α-Reductase Inhibitors in the Hamster Flank Organ and Ear11The research has been supported by Endorecherche that is seeking patent protection for the new compounds. F. Labrie is President of Endorecherche.
- Diagnosis and treatments of hirsutism: where are we?
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- Management of congenital ichthyoses: European guidelines of care, part two